Journal of the Korean neurological association (대한신경과학회지)

Korean Neurological Association (대한신경과학회)
권호 표지
DOI QR코드

DOI QR Code

Diagnosis of Multiple Sclerosis: 2017 McDonald Diagnostic Criteria

다발경화증의 진단: 2017 맥도널드진단기준

  • Sohn, Eun Hee (Department of Neurology, Chungnam National University Hospital) ;
  • Jeong, Seung-Hae (Department of Neurology, Chungnam National University Hospital)
  • 손은희 (충남대학교병원 신경과) ;
  • 정성해 (충남대학교병원 신경과)
  • Received : 2018.08.09
  • Accepted : 2018.09.11
  • Published : 2018.11.30
⟨ Previous Next ⟩

Abstract

Multiple sclerosis (MS) is a diagnosis of exclusion and the lesions or objective findings should disseminate in space and time to diagnose MS. The diagnostic criteria of MS have continuously evolved overtime. The McDonald criteria were originally proposed in 2001, and the revised 2010 McDonald criteria have been used widely. Scientific advances in the past 7 years since 2010 induced the revised 2017 McDonald criteria. All revisions relied entirely on the available evidences, and not expert opinion. In this review, we will provide an overview of the way to diagnose MS and the 2017 McDonald criteria.

Keywords

References

  1. Schumacher GA, Beebe G, Kibler RF, Kurland LT, Kurtzke JF, McDowell F, et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci 1965;122:552-568.
  2. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231. https://doi.org/10.1002/ana.410130302
  3. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-127. https://doi.org/10.1002/ana.1032
  4. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005;58:840-846. https://doi.org/10.1002/ana.20703
  5. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302. https://doi.org/10.1002/ana.22366
  6. Filippi M, Rocca MA, Ciccarelli O, De Stefano N, Evangelou N, Kappos L, et al. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol 2016;15:292-303. https://doi.org/10.1016/S1474-4422(15)00393-2
  7. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018;17:162-173. https://doi.org/10.1016/S1474-4422(17)30470-2
  8. Solomon AJ, Bourdette DN, Cross AH, Applebee A, Skidd PM, Howard DB, et al. The contemporary spectrum of multiple sclerosis misdiagnosis: a multicenter study. Neurology 2016;87:1393-1399. https://doi.org/10.1212/WNL.0000000000003152
  9. Brownlee WJ, Hardy TA, Fazekas F, Miller DH. Diagnosis of multiple sclerosis: progress and challenges. Lancet 2017;389:1336-1346. https://doi.org/10.1016/S0140-6736(16)30959-X
  10. Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 2008;14:1157-1174. https://doi.org/10.1177/1352458508096878
  11. McNicholas N, Hutchinson M, McGuigan C, Chataway J. 2017 McDonald diagnostic criteria: a review of the evidence. Mult Scler Relat Disord 2018;24:48-54. https://doi.org/10.1016/j.msard.2018.05.011
  12. Caucheteux N, Maarouf A, Genevray M, Leray E, Deschamps R, Chaunu MP, et al. Criteria improving multiple sclerosis diagnosis at the first MRI. J Neurol 2015;262:979-987. https://doi.org/10.1007/s00415-015-7668-9
  13. Kang H, Metz LM, Traboulsee AL, Eliasziw M, Zhao GJ, Cheng Y, et al. Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes. Mult Scler 2014;20:458-463. https://doi.org/10.1177/1352458513501230
  14. Tintore M, Rovira A, Brieva L, Grive E, Jardi R, Borras C, et al. Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS. Mult Scler 2001;7:359-363. https://doi.org/10.1177/135245850100700603
  15. Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman CH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120 (Pt 11):2059-2069. https://doi.org/10.1093/brain/120.11.2059
  16. Wegner C, Stadelmann C. Gray matter pathology and multiple sclerosis. Curr Neurol Neurosci Rep 2009;9:399-404. https://doi.org/10.1007/s11910-009-0058-x
  17. Geurts JJ, Stys PK, Minagar A, Amor S, Zivadinov R. Gray matter pathology in (chronic) MS: modern views on an early observation. J Neurol Sci 2009;282:12-20. https://doi.org/10.1016/j.jns.2009.01.018
  18. Filippi M, Rocca MA, Calabrese M, Sormani MP, Rinaldi F, Perini P, et al. Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology 2010;75:1988-1994. https://doi.org/10.1212/WNL.0b013e3181ff96f6
  19. Okuda DT, Mowry EM, Beheshtian A, Waubant E, Baranzini SE, Goodin DS, et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology 2009;72:800-805. https://doi.org/10.1212/01.wnl.0000335764.14513.1a
  20. Okuda DT, Siva A, Kantarci O, Inglese M, Katz I, Tutuncu M, et al. Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS One 2014;9:e90509. https://doi.org/10.1371/journal.pone.0090509
  21. Kantarci OH, Lebrun C, Siva A, Keegan MB, Azevedo CJ, Inglese M, et al. Primary progressive multiple sclerosis evolving from radiologically isolated syndrome. Ann Neurol 2016;79:288-294. https://doi.org/10.1002/ana.24564
  22. Bever CT Jr, Grattan L, Panitch HS, Johnson KP. The brief repeatable battery of neuropsychological tests for multiple sclerosis: a preliminary serial study. Mult Scler 1995;1:165-169. https://doi.org/10.1177/135245859500100306
  23. Lebrun C, Blanc F, Brassat D, Zephir H, de Seze J. Cognitive function in radiologically isolated syndrome. Mult Scler 2010;16:919-925. https://doi.org/10.1177/1352458510375707
  24. Lebrun C, Cohen M, Clavelou P. Evaluation of quality of life and fatigue in radiologically isolated syndrome. Rev Neurol (Paris) 2016;172:392-395. https://doi.org/10.1016/j.neurol.2016.04.004
  25. Azevedo CJ, Overton E, Khadka S, Buckley J, Liu S, Sampat M, et al. Early CNS neurodegeneration in radiologically isolated syndrome. Neurol Neuroimmunol Neuroinflamm 2015;2:e102. https://doi.org/10.1212/NXI.0000000000000102
  26. Okuda DT, Mowry EM, Cree BA, Crabtree EC, Goodin DS, Waubant E, et al. Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology 2011;76:686-692. https://doi.org/10.1212/WNL.0b013e31820d8b1d
  27. Lebrun C, Le Page E, Kantarci O, Siva A, Pelletier D, Okuda DT. Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort. Mult Scler 2012;18:1297-1302. https://doi.org/10.1177/1352458511435931
  28. Stangel M, Fredrikson S, Meinl E, Petzold A, Stuve O, Tumani H. The utility of cerebrospinal fluid analysis in patients with multiple sclerosis. Nat Rev Neurol 2013;9:267-276.
  29. Brundin L. CSF examination still has value in the diagnosis of MS-YES. Mult Scler 2016;22:994-995. https://doi.org/10.1177/1352458516642853
  30. Arrambide G, Tintore M. CSF examination still has value in the diagnosis of MS - Commentary. Mult Scler 2016;22:997-998. https://doi.org/10.1177/1352458516642033
  31. Tintore M, Rovira A, Rio J, Tur C, Pelayo R, Nos C, et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology 2008;70:1079-1083. https://doi.org/10.1212/01.wnl.0000280576.73609.c6
  32. Tintore M, Rovira A, Rio J, Otero-Romero S, Arrambide G, Tur C, et al. Defining high, medium and low impact prognostic factors for developing multiple sclerosis. Brain 2015;138:1863-1874. https://doi.org/10.1093/brain/awv105
  33. Huss AM, Halbgebauer S, Ockl P, Trebst C, Spreer A, Borisow N, et al. Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndrome. J Neurol 2016;263:2499-2504. https://doi.org/10.1007/s00415-016-8302-1
  34. Andersson M, Alvarez-Cermeno J, Bernardi G, Cogato I, Fredman P, Frederiksen J, et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 1994;57:897-902. https://doi.org/10.1136/jnnp.57.8.897
  35. Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni G, Grimsley G, Keir G, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol 2005;62:865-870.